HIV Clinical Topics in Antiretroviral Therapy 2026

Josep M Llibre, MD, PhD, received his MD in the Universitat de Barcelona, and obtained his specialty in Internal Medicine and his PhD in the Universitat Autònoma de Barcelona. He is a member of the panel of Antiretroviral treatment guidelines at the GeSIDA group (AIDS group of the SEIMC Spanish society), and an expert advisor of the Catalan Health Institute (ICS) on antiretroviral treatment and hepatitis C (PADEICS). He started caring for patients with HIV/AIDS at the beginning of the epidemic in Spain in 1987. His main areas of interest in HIV Medicine include the clinical implications of HIV-1 resistance, the analysis of safety and efficacy in HIV-1 antiretroviral treatment clinical trials (both in naïve and pre-treated patients), with a special interest in drug efficacy and pharmacoeconomics, and hepatitis C co-infection. He has published widely in journals and book chapters, as well as HIV/AIDS medical webs, on clinical aspects of HIV-1 treatment and care, HIV-1 resistance, clinical reviews, positioning papers, treatment intensification and simplification strategies, and participated in many pivotal clinical trials. He has also published in basic science research journals. He collaborates as an editor and/or peer-reviewing with many top international medical journals. He is involved in HIV Medical Educational training in Spain and other European, as well as Asian Countries.

Cristina Mussini has been Full Professor of Infectious Diseases at the University of Modena and Reggio Emilia in Italy since 2011. She is also the Director of the Clinic of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico, in Modena, Italy. She received her degree in medicine and surgery from the University of Modena in 1987 and completed a specialization in infectious diseases in 1990.

Cristina has published more than 200 papers in index journals with a total of above 900 and with an H-index of 55 (Google Scholar).

Cristina is a long-standing member of several organizations, including: the National AIDS Committee of the Italian Ministry of Health from 2009 to 2016; the Governing Board of the European AIDS Clinical Society since 2000; and the Scientific Committees for the European AIDS Conferences, HIV Glasgow and the Icona Cohort Study since 2008. She is Chair of the ESGIE, the ESCMID Study Group for Infections in the Elderly.

University of Bonn, Germany

He completed his specialty at the Hospital Universitari Germans Trias i Pujol, with a stay at the Infectious Diseases service of the La Pitié-Salpêtrière University Hospital in Paris-France. At the end of his specialty, he oriented his clinical practice to the treatment of infectious pathologies, mainly HIV-infected patients and associated pathologies, as well as infectious pathologies that are difficult to manage.

For more than 7 years, he dedicated himself to the study of pathologies related to Human Papilloma Virus (HPV) infection in the HIV-infected population, a field in which he completed his doctoral thesis, finishing it in 2019. He obtained his degree in doctor of medicine with the highest qualification (Cum laude) for the publications he made in the field of prevention of anal cancer related to HPV infection, being the main author of the first publication worldwide that demonstrated the usefulness of anoscopy resolution as a prevention strategy for anal cancer.

During the COVID-19 epidemic, he led the first study that demonstrated the usefulness of screening with antigen tests to be able to carry out massive cultural events during the concerts of Love of Lesbian and the Sala Apolo in Barcelona, ​​events that had a great impact worldwide. and that their results were published in the prestigious journals Lancet ID and Annals of Internal Medicine.

Dr. Revollo has worked for three years as a volunteer with the NGO Médecins Sans Frontières – France in different countries on the African continent such as the Democratic Republic of the Congo, the Central African Republic, Tchad, Sudan, always orienting his clinical practice towards the treatment of infectious pathologies.

Cristiana Oprea MD, Ph.D. is Associate Professor at Carol Davila University of Medicine and Pharmacy in Bucharest, a practicing specialist in infectious diseases and the Head of the Clinical Infectious diseases Department I at “Victor Babes” Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

Since 1993, the peak of the paediatric HIV epidemic in Romania, Dr Oprea has been actively involved in the management and treatment of children belonging to the Romanian HIV paediatric cohort (infected by parenteral mode in their first years of life, in the late ‘80s), continuing with adolescents and young adults, then facing the new HIV epidemic in injecting drug users and MSM and the increase in HIV/TB cases.Dr Oprea’s research interest is focused on HIV and opportunistic infections, co-infections with viral hepatitis, HIV in women and MTCT of HIV, and Standards of care for HIV and Co-infections in Central and Eastern Europe.

Dr Oprea was involved in research projects and clinical trials on treatment of HIV and hepatitis and in PENTA. She is a member of EuroSIDA Steering Committee and of the scientific committee of WAVE (women against viruses in Europe). She was part of the European AIDS Clinical Society (EACS) Governing board between 2014-2024 and of the scientific committee of ECCMID between 2018-2022. She is currently chair of the panel of opportunistic infections section for the EACS guidelines and co-chair of the EACS Standard of care meeting for HIV and coinfections.

Infectious Diseases Specialist, both in outpatient and inpatient settings. Infectious Diseases teacher in Lisbon School of Medicine, University of Lisbon.

Teymur Noori is a psychologist and works at the European Centre for Disease Prevention and Control (ECDC) as an expert on monitoring and evaluation. He is primarily responsible for monitoring the HIV response in Europe and Central Asia, including monitoring the continuum of HIV care and supporting efforts to monitor the response to viral hepatitis in the EU/EEA. He has recently led efforts to develop a monitoring and evaluation framework for COVID-19 surveillance, preparedness and response indicators in the EU/EEA. Teymur is also leading ECDC work on migrant health and infectious diseases. He recently led ECDC work to develop guidance on screening and vaccination of infectious diseases among newly arrived migrants in the EU/EEA as well as guidance on infection prevention and control of COVID-19 in migrant and refugee reception centres in the EU/EEA.